Serum leptin, resistin and TNF-α Levels in patients with systemic sclerosis: The role of adipokines in scleroderma

International Journal of Rheumatic Diseases

Volumn 15, Issue 4, 2012, Pages 374-379

  Pehlivan, Yavuz ^a   Onat, Ahmet Mesut ^a   Ceylan, Nurdan ^a   Turkbeyler, Ibrahim Halil ^a   Buyukhatipoglu, Hakan ^a   Comez, Gazi ^a   Babacan, Taner ^a   Tarakcioglu, Mehmet ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Leptin; Resistin; Systemic sclerosis; TNF

Indexed keywords

ADIPOCYTOKINE; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL; RANK SUM TEST; SCLERODERMA; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HUMANS; LEPTIN; RESISTIN; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SEVERITY OF ILLNESS INDEX; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865291653     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2012.01755.x     Document Type: Article

References (34)

1. Chizzolini C (2007) Update on pathophysiology of scleroderma with special reference to immunoinflammatory events. Ann Med 39, 42-53.
2. Sfrent-Cornateanu R, Mihai C, Balan S, Ionescu R, Moldoveanu E (2006) The IL-6 promoter polymorphism is associated with disease activity and disability in systemic sclerosis. J Cell Mol Med 10, 955-9.
3. Bokarewa M, Bokarew D, Hultgren O, Tarkowski A (2003) Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 62, 952-6.
4. Bernotiene E, Palmer G, Gabay C (2006) The role of leptin in innate and adaptive immune responses. Arthritis Res Ther 8, 217.
5. Hizmetli S, Kisa M, Gokalp N, Bakici MZ (2007) Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis? Rheumatol Int 27, 335-8.
6. Considine RV, Sinha MK, Heiman ML et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334, 292-5.
7. Palmer G, Gabay C (2003) A role for leptin in rheumatic disease. Ann Rheum Dis 62, 913-5.
8. Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IS et al. (2002) Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int 22, 138-41.
9. Kotulska A, Kucharz EJ, Brzeziñska-Wcislo L, Wadas U (2001) A Decreased Serum Leptin Level in Patients with Systemic Sclerosis. Clin Rheumatol 20, 300-2.
10. Riccieri V, Stefanantoni K, Vasile M et al. (2011) Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Clin Exp Rheumatol 29, 46-52.
11. Migita K, Maeda Y, Miyashita T et al. (2006) The serum levels of resistin in rheumatoid arthritis patients. Clin Exp Rheumatol 24, 698-701.
12. Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA (2006) Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 12, 100-5.
13. McTernan PG, Kusminski CM, Kumar S (2006) Resistin. Curr Opin Lipidol 17, 170-5.
14. Hui-Bing H, Migita K, Miyashita T et al. (2006) Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus. Metabolism 55, 1670-3.
15. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23, 581-90.
16. Valentini G, Della Rossa A, Bombardieri S et al. (2001) European multicentre study to define disease activity criteria for systemic syclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60, 592-8.
17. Clements PJ, Lachenbruch PA, Seibold JR et al. (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 22, 1281-5.
18. LeRoy EC, Black C, Fleischmajer R et al. (1988) Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 15, 202-5.
19. Otero M, Lago R, Lago F et al. (2005) Leptin, from fat to inflammation: old questions and new insights. FASEB J 17, 295-301.
20. Sarraf P, Frederich RC, Turner EM et al. (1997) Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 185, 171-5.
21. Gualillo O, Eiras S, Lago F, Dieguez C, Casanueva FF (2000) Elevated serum leptin concentrations induced by experimental acute inflammation. Life Sci 67, 2433-41.
22. Popa C, Netea MG, Radstake TR et al. (2005) Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 64, 1195-8.
23. Zhang HH, Kumar S, Barnett AH, Eggo MC (2000) Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release. Mol Cell Endocrinol 159, 79-88.
24. Toussirot E, Gaugler B, Bouhaddi M et al. (2010) Elevated adiponectin serum levels in women with systemic autoimmune diseases. Mediators Inflamm 2010, 938408. Epub 26 December 2010.
25. Inui A (1999) Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res 59, 4493-501.
26. Kim HA, Choi GS, Jeon JY, Yoon JM, Sung JM, Suh CH (2010) Leptin and ghrelin in Korean systemic lupus erythematosus. Lupus 19, 170-4.
27. Salazar-Paramo M, Gonzalez-Ortiz M, Gonzalez-Lopez L et al. (2001) Serum leptin levels in patients with rheumatoid arthritis. J Clin Rheumatol 7, 55-9.
28. Yoshino T, Kusunoki N, Tanaka N et al. (2011) Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med 50, 269-75.
29. Anagnostoulis S, Karayiannakis AJ, Lambropoulou M, Efthimiadou A, Polychronidis A, Simopoulos C (2008) Human leptin induces angiogenesis in vivo. Cytokine 42, 353-7.
30. Stejskal D, Adamovska S, Bartek J, Jurakova R, Praskova J (2003) Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147, 63-9.
31. Al-Daghri N, Chetty R, McTernan PG et al. (2005) Serum resistin is associated with c-reactive protein and LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovasc Diabetol 4, 10.
32. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A (2005) Resistin, an adipokine with potent pro-inflammatory properties. J Immunol 174, 5789-95.
33. Almehed K, d'Elia HF, Bokarewa M, Carlsten H (2008) Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther 10, 15.
34. Alekperov RT, Timchenko AV, Nasonov EL (2003) Tumor necrosis factor alpha in systemic scleroderma. Klin Med (Mosk) 81, 4-7.